Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: Evidence for participation of insulin resistance

Clinical Cancer Research

Volumn 11, Issue 10, 2005, Pages 3642-3646

  Otake, Sayaka ^a   Takeda, Hiroaki ^a   Suzuki, Yasukuni ^a   Fukui, Tadahisa ^a   Watanabe, Shinichiro ^a   Ishihama, Katsuyoshi ^a   Saito, Takafumi ^a   Togashi, Hitoshi ^a   Nakamura, Tadashi ^b   Matsuzawa, Yuji ^b   Kawata, Sumio ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; COLORECTAL ADENOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID STORAGE; LOGISTIC REGRESSION ANALYSIS; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; VISCERA;

ADENOMA; ADIPONECTIN; ADIPOSE TISSUE; AGED; BODY COMPOSITION; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIET; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 21044459814     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1868     Document Type: Article

References (40)

1. Potter JD, Slatter ML, Bostick RM, et al. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15:499-545.
2. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and indent colorectal cancer. J Natl Cancer Inst 1999;91:1147-54.
3. Giovannucci E, Aasherio A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122:327-34.
4. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987;36:54-9.
5. Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Res Rev 1997;13:3-13.
6. Shuman WP, Newell-Morris LL, Leonetti DL, et al. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 1986;21:483-7.
7. Seidell JG, Oosterlee A, Thijssen MA, et al. Assessment of intra-abdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography. Am J Clin Nutr 1987;45:7-13.
8. Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003;52:172-9.
9. Kanai H, Tokunaga K, Fujioka S, et al. Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension 1996;27:125-9.
10. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
11. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9.
12. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-9.
13. Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002;51:2325-8.
14. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-301.
15. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003;107:671.
16. Engeli S, Feldpausch M, Gorzelniak K, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003;52:942-7.
17. Petridou E, Mantzoros C, Dessypris N, et al. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003;88:993-7.
18. Miyoshi Y, Funahashi T, Kihara S, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;15:5699-704.
19. The Expert Committee. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:11833-1197.
20. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
21. Tokunaga K, Matsuzawa Y, Ishikawa K, et al. A novel technique for determination of body fat by computed tomography. Int J Obes 1983;7:437-45.
22. Larsson B, Svardsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984;288:1401-4.
23. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-60.
24. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women [published erratum appears in JAMA 1993;269: 1254]. JAMA 1993;269:483-7.
25. Sellers TA, Kushi LH, Potter JD, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer [published erratum appears in N Engl J Med 1992;327: 1612]. N Engl J Med 1992;326:1323-9.
26. Gann PH, Daviglus ML, Dyer AR, et al. Heart rate and prostate cancer mortality: results of a prospective analysis. Cancer Epidemiol Biomarkers Prev 1995;4:611-6.
27. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731-7.
28. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-95.
29. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-9.
30. Kern PA, Di Gregorio GB, Lu T, et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 2003;52:1779-85.
31. Goldfine AB, Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003;362:1431-2.
32. Snehalathan C, Mukesh B, Simon M, et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003;26:3226-9.
33. Zietz B, Herfarth H, Paul G, et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 2003;19:103-4.
34. Yokota T, Oritani K, Ishikawa J, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723-32.
35. Mantzoros C, Petridou E, Dessypris N, et al. Adiponectin and breast cancer. J Clin Endocrinol Metab 2004;89:1102-7.
36. Nishii T, Kono S, Abe H, Eguchi H, et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese. Jpn J Cancer Res 2001;92:836-40.
37. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109-20S.
38. Ma J, Pollak MN, Giovannucci E, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl cancer Inst 1999;91:620-5.
39. Renehan AG, Painter JE, Atkin WS, et al. High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg 2001;88:107-13.
40. Kriketos AD, Gan SK, Poynten AM, et al. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 2004;27:629-30.